Urologic oncologist @UABUrology. SUO fellow @MayoUrology. Urology resident @PennUrology. Passionate about caring for those with cancer. Views are my own.
Birmingham, AL
Joined December 2018
- Tweets141
- Following358
- Followers369
- Likes984
Dan Roberson retweeted
We’re excited to welcome three new faculty members to the @UABHeersink Dept. of Urology!
Please join us in welcoming Daniel Roberson, M.D., Cameron Britton, M.D., and David Patrick Murray, M.D., who joined our department on Sept. 1 as assistant professors.
ALT Welcome announcement for UAB Medicine Urology introducing three new assistant professor physicians, shown as three professional headshots in white coats beneath a bold "Welcome, New Faculty!" headline and the UAB Medicine logo.
Dan Roberson retweeted
Bladder Preservation After Neoadjuvant Chemotherapy: Stick to the Plan! -
auanews.net/issues/articles/…
@AmerUrological @IBCG_BladderCA @AmyLuckenbaugh @shilpaonc @ARRODRIGUEZMD #BladderCancer
Dan Roberson retweeted
Congratulations to Vidit Sharma, MD, on his new role as Urologic Oncology Fellowship Program Director at @MayoUrology in Rochester, MN! 🎉
We are excited to see your leadership impact the future of urologic oncology!
#UrologyEducation #UrologicOncology #MayoClinic
There is undoubtedly an unmet need to improve the staging of bladder cancer. See our innovative, pilot study led by @vidit_sharma_ in @urogoldjournal. Prospective, in-vivo trial ongoing. Stay tuned for results.
🙏 @urogoldjournal for highlighting. Huge thanks to @DSRoberson93 and all collaborators
We are moving forward with in human trial of endoscopic ultrasound and core biopsy based on these ex vivo results.
Goal is to: see, stage and sample full thickness of bladder / tumor.
Dan Roberson retweeted
🙏 @urogoldjournal for highlighting. Huge thanks to @DSRoberson93 and all collaborators
We are moving forward with in human trial of endoscopic ultrasound and core biopsy based on these ex vivo results.
Goal is to: see, stage and sample full thickness of bladder / tumor.
HF-US combined with ultrasound-guided CNB accurately detects muscle-invasive bladder cancer in an ex-vivo setting. This approach could enhance precision in MIBC diagnosis, potentially improving patient outcomes and guiding treatment decisions. is.gd/Nu5VHJ @UroOnc
Nx+tumor thrombectomy in 617pts @MayoUrology : 9.2% G3+ comp rate,<1% mortality, IVC recon method not assoc w/ comp risk. Parsimonious nomogram with 3 preop variables (AUC=0.77 in validation). kwnsfk27.r.eu-west-1.awstrac… @vidit_sharma_ @BradLeibovichMD @ThielsCA @SBoorjian @SUO_YUO
Dan Roberson retweeted
🎉 Exciting news! We're proud to announce our 2027 #UrologicOncology Fellowship Match results! A huge congratulations to our matched fellows—we can't wait to see you grow & make an impact in the field! 👏🎊
#AUAMatch
Dan Roberson retweeted
When should venous tumor thrombus in RCC be managed urgently?
This week, @vidit_sharma_ joins @DSRoberson93 to discuss embolic risk, patient optimization, and practical decision-making in managing venous tumor thrombus in renal cell carcinoma #URO300 @MayoUrology
na2.hubs.ly/H059Yh00
Dan Roberson retweeted
A validated prediction tool is now available to assess metastatic recurrence risk post-surgery for non-metastatic renal cell carcinoma with venous tumor thrombus. is.gd/x3VLUG @UroOnc
Dan Roberson retweeted
What do you do when metastatic urothelial cancer has a dramatic response to systemic therapy? This week, @abhinav__khanna and @DSRoberson93 discuss consolidative cystectomy and the evolving role of surgery in advanced disease #URO290
na2.hubs.ly/H03M8nW0
Dan Roberson retweeted
Good chat w/ great friends re: consolidative surgery in advanced urothelial carcinoma
An emerging paradigm of surgical consolidation opens an opportunity for cessation systemic therapy w/ definitive pathologic staging
Initial results @EuropeanUrology
with more data to come!
📺 In a new series, @DSRoberson93 and @abhinav__khanna of @MayoUrology and @NitinYerram of @HUMCUrology explore cytoreductive cystectomy in the post–EV-302 era.
👉 Learn how the success of EV-302 has created a subset of patients with durable responses: buff.ly/IXO7bVq
Dan Roberson retweeted
📺 In a new series, @DSRoberson93 and @abhinav__khanna of @MayoUrology and @NitinYerram of @HUMCUrology explore cytoreductive cystectomy in the post–EV-302 era.
👉 Learn how the success of EV-302 has created a subset of patients with durable responses: buff.ly/IXO7bVq
Dan Roberson retweeted
Excited to share our second year Urologic Oncology fellow, Dan Roberson, MD, as the featured SUO fellow in the most recent issue of @UrolOncol to honor the amazing accomplishments of SUO fellows. Click the link below to get to know @dsroberson93 better!
bit.ly/4naYx8z
Dan Roberson retweeted
How fast do #rcc tumor thrombi grow? 📈 In our cohort @MayoUrology (n=141), venous tumor thrombi expanded ~1 cm/month (wide range). Faster growth seen with higher Mayo level, sarcomatoid/rhabdoid features & metastasis. These data can guide pre-op imaging & surgical triage.
ALT https://pubmed.ncbi.nlm.nih.gov/40857748/
ALT We compared thrombus extent at initial presentation before referral and at the immediate pre-op scan. Median of 20 days between scans.
ALT 11% reclassification between initial and subsequent scan.
ALT Factors can be plugged into our predicted growth table to estimate growth
Dan Roberson retweeted
🚨 New in European Urology:
Consolidative surgery after #EnfortumabVedotin +/– ICI in advanced urothelial carcinoma:
✅ 82% downstaging
✅ 43% ypT0N0
✅ 79% stopped systemic therapy
✅ 89% DFS in curative group
📄 buff.ly/RFs0J5N
#BladderCancer #Immunotherapy #Urology
Dan Roberson retweeted
In analysis of over 2,000 open RC patients, Mayo Clinic researchers found that prophylactic iNPWT was associated with lower odds of SSI. Further investigation is warranted though this low cost/risk intervention may reduce morbidity for select patients
vist.ly/43c5x
Dan Roberson retweeted
Bladder tumor hard to reach intraluminally or pt not TURBT candidate? In 59 percutaneous biopsies, 95% diagnostic yield, 93% concordance with TURBT/surgical pathology, 0% bladder perf/leak. Another tool for #bladdercancer providers.
vist.ly/32n5q
Dan Roberson retweeted
Thank you for the support, good to be back.
It is our pleasure to welcome back our newest faculty member, Leilei Xia, MD.
For more on @LeileiXiaUro, please visit: instagram.com/pennsurgery
Dan Roberson retweeted
🎉 Exciting news! We're proud to announce our 2026 #UrologicOncology Fellowship Match results!
A huge congratulations to our matched fellows—we can't wait to see you grow & make an impact in the field! 👏🎊
@UroOnc #AUAMatch @Uroweb @SBoorjian @vidit_sharma_ @SUO_YUO
